-
Adults (18-64 years)
-
General population
-
SARS-CoV-2
-
Post COVID-19 condition
-
Post-acute infection syndrome
-
Non pharmacological intervention
-
Rehabilitation
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Hospital
-
Outpatient clinic
-
SARS-CoV-2
-
Pharmacological intervention
-
Antivirals
-
Nirmatrelvir/Ritonavir
-
Molnupiravir
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Hospital
-
Outpatient clinic
-
SARS-CoV-2
-
Pharmacological intervention
-
Antivirals
-
Remdesivir
-
Adults (18-64 years)
-
General population
-
Hospital
-
Outpatient clinic
-
Monkeypox virus
-
Pharmacological intervention
-
Vaccination
-
MVA-BN
-
Adults (18-64 years)
-
General population
-
SARS-CoV-2
-
Post COVID-19 condition
-
Post-acute infection syndrome
-
Non pharmacological intervention
-
Rehabilitation
-
Neurostimulation
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Hospital
-
Outpatient clinic
-
SARS-CoV-2
-
Post COVID-19 condition
-
Post-acute infection syndrome
-
Adults (18-64 years)
-
People at high risk of STIs
-
Men who have sex with men
-
Hospital
-
Outpatient clinic
-
Monkeypox virus
-
Adults (18-64 years)
-
General population
-
SARS-CoV-2
-
Post COVID-19 condition
-
Post-acute infection syndrome
-
Non pharmacological intervention
-
Rehabilitation
-
Neurostimulation
-
Adults (18-64 years)
-
People at high risk of STIs
-
Hospital
-
Outpatient clinic
-
Monkeypox virus
-
Blood sample
-
Adults (18-64 years)
-
General population
-
Hospital
-
Non-hospital health centre
-
Vaccination centre
-
Monkeypox virus
-
Blood sample
-
Pharmacological intervention
-
Vaccination
-
MVA-BN
-
Adults (18-64 years)
-
General population
-
Non-hospital health centre
-
Vaccination centre
-
Monkeypox virus
-
Pharmacological intervention
-
Vaccination
-
Adults (18-64 years)
-
General population
-
Non-hospital health centre
-
Vaccination centre
-
Monkeypox virus
-
Pharmacological intervention
-
Vaccination